6-Aminopenicillanic Acid (CAS 551-16-6): A Cornerstone Pharmaceutical Intermediate
In the realm of pharmaceutical manufacturing, certain chemical compounds stand out for their foundational importance. 6-Aminopenicillanic Acid (CAS 551-16-6), commonly known as 6-APA, is one such critical intermediate. Its role in the synthesis of life-saving penicillin-class antibiotics makes it a cornerstone of the pharmaceutical industry. This article delves into the properties, applications, and market significance of 6-APA, emphasizing why sourcing it from reliable suppliers is essential.
Understanding 6-Aminopenicillanic Acid
6-APA is a derivative of penicillin G, obtained through enzymatic or chemical deacylation. Its chemical structure, characterized by a fused beta-lactam and thiazolidine ring system, along with an amino group at the 6th position, is key to its utility. While 6-APA itself possesses very limited antibacterial activity, the amino group provides a reactive site for the attachment of various side chains. This modification capability is what enables the creation of a broad spectrum of semi-synthetic penicillins with tailored pharmacological profiles.
Key Chemical and Physical Properties
For pharmaceutical applications, understanding the specifications of 6-APA is crucial. Typical characteristics include:
- Appearance: White or almost white crystalline powder.
- Assay: High purity, usually ≥99.0%, is critical for effective synthesis.
- Solubility: Soluble in water and acidic solutions, with pH-dependent solubility.
- Stability: Relatively stable under acidic conditions but susceptible to hydrolysis in alkaline environments.
- Optical Rotation: Exhibits a specific optical rotation, typically around +265° to +285°.
These properties dictate how 6-APA behaves during synthesis and its suitability for specific pharmaceutical formulations.
Applications Driving Demand for 6-APA
The primary demand for 6-APA stems from its role as a key intermediate in the production of semi-synthetic penicillins, which are extensively used in both human and veterinary medicine:
- Human Medicine: It is fundamental for synthesizing ampicillin, amoxicillin, carbenicillin, ticarcillin, and piperacillin, among others. These antibiotics are vital for treating a wide range of bacterial infections.
- Veterinary Medicine: Penicillin-based antibiotics derived from 6-APA are also crucial for treating bacterial diseases in livestock and companion animals, ensuring animal welfare and food safety.
The ability to modify the side chain of 6-APA allows for the development of antibiotics with improved absorption, broader spectrum of activity, and resistance to bacterial beta-lactamase enzymes.
The Importance of Partnering with Reliable Suppliers
When you need to buy 6-Aminopenicillanic Acid, selecting a dependable supplier is non-negotiable. A reputable manufacturer ensures that the 6-APA you source meets stringent quality standards, providing consistency and reliability for your production processes. As a leading manufacturer and supplier in China, we are dedicated to providing high-purity 6-APA (CAS 551-16-6) that meets global pharmaceutical requirements. We invite you to contact us for detailed specifications, pricing, and to discuss how our 6-APA can support your manufacturing needs.
Conclusion
6-Aminopenicillanic Acid is an indispensable component in the modern pharmaceutical armamentarium. Its role as a precursor to essential antibiotics underscores the importance of careful sourcing. By choosing a reliable manufacturer and supplier, companies can ensure the quality and efficacy of their antibiotic products.
Perspectives & Insights
Quantum Pioneer 24
“These properties dictate how 6-APA behaves during synthesis and its suitability for specific pharmaceutical formulations.”
Bio Explorer X
“Veterinary Medicine: Penicillin-based antibiotics derived from 6-APA are also crucial for treating bacterial diseases in livestock and companion animals, ensuring animal welfare and food safety.”
Nano Catalyst AI
“The ability to modify the side chain of 6-APA allows for the development of antibiotics with improved absorption, broader spectrum of activity, and resistance to bacterial beta-lactamase enzymes.”